|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
|
GT200500281A
(en)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
ORGANIC COMPOUNDS.
|
|
GB0424284D0
(en)
|
2004-11-02 |
2004-12-01 |
Novartis Ag |
Organic compounds
|
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
US7994211B2
(en)
|
2005-08-08 |
2011-08-09 |
Argenta Discovery Limited |
Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
|
|
GB0516313D0
(en)
|
2005-08-08 |
2005-09-14 |
Argenta Discovery Ltd |
Azole derivatives and their uses
|
|
MY144906A
(en)
|
2005-10-21 |
2011-11-30 |
Novartis Ag |
Human antibodies against il13 and therapeutic uses
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
AR059216A1
(en)
|
2006-01-27 |
2008-03-19 |
Sun Pharmaceutical Ind Ltd |
11B-HYDROXIANDROSTA-4-ENO-3-ONAS
|
|
GB0601951D0
(en)
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
|
RU2457209C2
(en)
|
2006-04-21 |
2012-07-27 |
Новартис Аг |
Purine derivatives applicable as adenosine receptor a2a agonists
|
|
HRP20110201T1
(en)
|
2007-01-10 |
2011-08-31 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS OF CANALIZED ACTIVATION
|
|
DE602008005140D1
(en)
|
2007-05-07 |
2011-04-07 |
Novartis Ag |
ORGANIC CONNECTIONS
|
|
AR069637A1
(en)
|
2007-12-10 |
2010-02-10 |
Novartis Ag |
PIRAZINE DERIVATIVES
|
|
WO2009150137A2
(en)
|
2008-06-10 |
2009-12-17 |
Novartis Ag |
Organic compounds
|
|
PL2379507T3
(en)
|
2008-12-30 |
2014-03-31 |
Pulmagen Therapeutics Inflammation Ltd |
Sulfonamide compounds for the treatment of respiratory disorders
|
|
JP2013508414A
(en)
|
2009-10-22 |
2013-03-07 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Compositions for the treatment of cystic fibrosis and other chronic diseases
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
UY33597A
(en)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
BR112013021638A2
(en)
|
2011-02-25 |
2016-08-02 |
Irm Llc |
"trk inhibiting compounds, their use and compositions comprising them"
|
|
UY34305A
(en)
|
2011-09-01 |
2013-04-30 |
Novartis Ag |
DERIVATIVES OF BICYCLIC HETEROCICLES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
|
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
CN103946221B
(en)
|
2011-09-16 |
2016-08-03 |
诺华股份有限公司 |
Heterocyclic compounds for the treatment of cystic fibrosis
|
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
|
ES2882807T3
(en)
|
2011-09-16 |
2021-12-02 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
ES2664019T3
(en)
|
2013-05-28 |
2018-04-18 |
Sun Pharma Advanced Research Company Limited |
Methods for the treatment of inflammatory conditions by the use of s- [4- (3-fluoro-3-methylbutyryloxy) but-2-inyl] 6alpha, 9alpha-difluoro-17alpha- (furan-2-yl) carbonyloxy-11beta - hydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta -carbonate
|
|
US10155001B2
(en)
|
2013-06-14 |
2018-12-18 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
RAC1 inhibitors for inducing bronchodilation
|
|
BR112016023967A2
(en)
|
2014-04-24 |
2017-08-15 |
Novartis Ag |
pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
CN106458979B
(en)
|
2014-04-24 |
2020-03-27 |
诺华股份有限公司 |
Aminopyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
EP3134396B1
(en)
|
2014-04-24 |
2019-09-18 |
Novartis AG |
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
CN108659090A
(en)
*
|
2017-03-31 |
2018-10-16 |
天津药业研究院有限公司 |
A kind of preparation method of 17 β-thiocarboxylic acids chloromethane esters steroidal compounds
|
|
AU2020290094B2
(en)
|
2019-06-10 |
2024-01-18 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF, COPD, and bronchiectasis
|
|
PE20220346A1
(en)
|
2019-08-28 |
2022-03-14 |
Novartis Ag |
1,3-HETEROARYL SUBSTITUTED DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES
|